We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Roche Diagnostics Licenses Rights to Use SYBR Green in Real Time PCR to Exiqon

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Roche Diagnostics and Exiqon A/S announced that they have entered into a license agreement for use of SYBR Green reagent in PCR.

Under the terms of the agreement, Exiqon obtains from Roche a non-exclusive license to use SYBR Green I in Real Time PCR. SYBR Green provides the simplest and most economical format for detecting and quantitating PCR products in Real-Time PCR reactions. Financial terms of the agreement were not disclosed.

“From our view, the licensing of the use of SYBR Green reagent in Real Time PCR reaction is an important contribution to further developing the PCR technology in the life science field,” states Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.

Roche and Exiqon signed an amendment to their 2005 license and distribution agreement for Exiqon’s Universal ProbeLibrary (UPL) already some weeks ago.